Search Results - "CASLEY, David J"

A Low-Sodium Diet Potentiates the Effects of Losartan in Type 2 Diabetes by HOULIHAN, Christine A, ALLEN, Terri J, BAXTER, Amynta L, PANANGIOTOPOULOS, Sianna, CASLEY, David J, COOPER, Mark E, JERUMS, George

“…A Low-Sodium Diet Potentiates the Effects of Losartan in Type 2 Diabetes Christine A. Houlihan , MBBS 1 , Terri J. Allen , PHD 1 , Amynta L. Baxter , BSC, MHN…”
Get full text

Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia by Nassis, Labrini, Frauman, Albert G., Ohishi, Mitsuru, Zhuo, Jialong, Casley, David J., Johnston, Colin I., Fabiani, Maurice E.

“…Benign prostatic hyperplasia (BPH) is the most common hyperplastic disease in man and it is characterized by increased cellular growth (stromal and epithelial…”
Get full text

Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes by COOPER, M. E, VRANES, D, YOUSSEF, S, STACKER, S. A, COX, A. J, RIZKALLA, B, CASLEY, D. J, BACH, L. A, KELLY, D. J, GILBERT, R. E

“…Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. M E Cooper , D Vranes , S Youssef ,…”
Get full text

Evidence for activation of the renin-angiotensin system in the human prostate: increased angiotensin II and reduced AT1 receptor expression in prostatic hyperplasia by DINH, Diem T, FRAUMAN, Albert G, SOMERS, Gino R, OHISHI, Mitsuru, JIALONG ZHOU, CASLEY, David J, JOHNSTON, Colin I, FABIANI, Maurice E

Get full text

Identification, Distribution, and Expression of Angiotensin II Receptors in the Normal Human Prostate and Benign Prostatic Hyperplasia by Dinh, Diem T., Frauman, Albert G., Sourial, Melissa, Casley, David J., Johnston, Colin I., Fabiani, Maurice E.

“…Abstract The tissue distribution, cellular localization, and level of expression of angiotensin II (Ang II) receptors were examined in the normal human…”
Get full text

Differential tissue and enzyme inhibitory effects of the vasopeptidase inhibitor omapatrilat in the rat by Kubota, Eiji, Dean, Rachael G, Hubner, Richard A, Casley, David J, Johnston, Colin I, Burrell, Louise M

“…Vasopeptidase inhibitors simultaneously inhibit angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP). The present study characterized the tissue…”
Get more information

In-vitro and in-vivo inhibition of rat neutral endopeptidase and angiotensin converting enzyme with the vasopeptidase inhibitor gemopatrilat by Hubner, Richard A, Kubota, Eiji, Casley, David J, Johnston, Colin I, Burrell, Louise M

“…OBJECTIVESVasopeptidase inhibitors are single molecules that simultaneously inhibit neutral endopeptidase (NEP) and angiotensin converting enzyme (ACE). The…”
Get full text

Angiotensin AT4 receptors in the normal human prostate and benign prostatic hyperplasia by Dinh, Diem T, Frauman, Albert G, Casley, David J, Johnston, Colin I, Fabiani, Maurice E

Get full text

In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan by Fabiani, Maurice E, Dinh, Diem T, Nassis, Labrini, Casley, David J, Johnston, Colin I

“…The present study examined the in vivo effects of candesartan cilexetil compared with losartan on angiotensin II (Ang II) receptor binding in the rat kidney…”
Get full text

Comparative in vivo effects of irbesartan and losartan on angiotensin II receptor binding in the rat kidney following oral administration by Fabiani, M E, Dinh, D T, Nassis, L, Casley, D J, Johnston, C I

“…We examined the ability of the new non-peptide angiotensin II receptor antagonist irbesartan to inhibit AT(1) receptors in vivo in the rat kidney following…”
Get more information

Identification, Distribution, and Expression of Angiotensin II Receptors in the Normal Human Prostate and Benign Prostatic Hyperplasia1 by Dinh, Diem T, Frauman, Albert G, Sourial, Melissa, Casley, David J, Johnston, Colin I, Fabiani, Maurice E

“…The tissue distribution, cellular localization, and level of expression of angiotensin II (Ang II) receptors were examined in the normal human prostate and…”
Get full text

Hypotensive effect of ZD7155, an angiotensin II receptor antagonist, parallels receptor occupancy in two-kidney, one-clip Goldblatt hypertensive rats by Yoshida, Kazunori, Perich, Rose, Casley, David J, Johnston, Colin I

“…OBJECTIVETo examine the effect of ZD7155, an angiotensin II receptor antagonist, on blood pressure, heart rate and occupancy of tissue angiotensin II receptor…”
Get full text

Evidence for activation of the renin-angiotensin system in the human prostate: increased angiotensin II and reduced AT1 receptor expression in benign prostatic hyperplasia by Dinh, Diem T., Frauman, Albert G., Somers, Gino R., Ohishi, Mitsuru, Zhou, Jialong, Casley, David J., Johnston, Colin I., Fabiani, Maurice E.

“…The expression and cellular localization of angiotensin II (Ang II) and AT1 receptor proteins were examined in the normal human prostate and benign prostatic…”
Get full text

Localization of endothelin receptors in rat kidney by Kohzuki, M, Johnston, C I, Chai, S Y, Casley, D J, Mendelsohn, F A

Get more information

Angiotensin II, Sodium, and Cardiovascular Hypertrophy in Spontaneously Hypertensive Rats by Harrap, Stephen B, Mitchell, Glenn A, Casley, David J, Mirakian, Christine, Doyle, Austin E

“…Angiotensin II (Ang II) may cause cardiovascular hypertrophy as a consequence of increased blood pressure or possibly by direct trophic actions. To dissociate…”
Get full text

Inhibition of Kidney Neutral Endopeptidase After Administration of the Neutral Endopeptidase Inhibitor Candoxatril: Quantitation by Autoradiography by Yoshida, Kazunori, Kanazawa, Masayuki, Casley, David J, Katopothis, Alexandra, Johnston, Colin I

“…Inhibition of neutral endopeptidase (NEP) in the kidney was studied ex vivo after oral administration of candoxatril (UK79300), an NEP inhibitor, to rats to…”
Get full text

Angiotensin-converting enzyme inhibition and salt in experimental myocardial infarction by YOSHIDA, K, KOHZUKI, M, CASLEY, D. J, JOHNSTON, C. I

Get full text

The inhibitory effect of [D-Arg1,D-Phe,D-Try7,9,Leu11] substance P on endothelin-1 binding sites in rat cardiac membranes by Gu, X H, Casley, D J, Nayler, W G

“…The specific binding of [125I]ET-1 to rat cardiac membrane fragments was inhibited by [D-Arg1,D-Phe, D-Try7,9,Leu11] substance P [substance P(D)], a potent…”
Get more information

Characterization of [125I]endothelin-1 binding sites in rat cardiac membrane fragments by Gu, X H, Casley, D J, Nayler, W G

“…Standard binding and displacement techniques were used to identify high-affinity binding sites for [125I]-labeled endothelin-1 (ET-1) in membranes harvested…”
Get more information

Reoxygenation, but neither hypoxia nor intermittent ischemia, increases [125I]endothelin-1 binding to rat cardiac membranes by Liu, J J, Gu, X H, Casley, D J, Nayler, W G

“…Standard binding techniques were used to establish whether either hypoxia, reoxygenation, perfusion under acidotic conditions, or "stunning" of the myocardium…”
Get more information